Trxade Group Inc (MEDS) Key Ratios

$0.97

up-down-arrow $0.01 (0.93%)

As on 04-Sep-2026 13:29EDT

Market cap

info icon

$3 Mln

Revenue (TTM)

info icon

$8 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

1.8

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 14.13 -77.15 -56.41 3.78 -9.59
EBIT -29.54 -33.83 -48.65 -480.05 -254.94
Net Profit -137.17 -175.21 -111.18 -428.46 -270.33
EPS -92.74 -32.05 -36.42 -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info -223.78-127.14-732.02-414.33-33.23
Net Margin info -----1,100.30----
Return on equity info 1,128.95635.00--3,545.19-357.65
Return on Capital info -80.78-81.84---458.64-46.26
Return on Assets info -655.36-422.82-130.76-230.71-23.78
Debt to Equity (x) info ----0.00-1.993.73
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
--
-458.64
-46.26
262.57
-109.46
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
--
3,545.19
-357.65
199.31
-145.76
Peer Median
26.56
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-130.76

Lower than Peers by 138.69

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
-130.76
-230.71
-23.78
-1,711.58
-95.17
Peer Median
7.92
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-732.02

Lower than Peers by 749.73

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
-732.02
-414.33
-33.23
--
-7.49
Peer Median
17.71
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-1,100.30

Lower than Peers by 1,118.70

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
-1,100.30
-433.95
-37.82
--
-8.37
Peer Median
18.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
0.00
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

-56.41

Lower than Peers by 69.09

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
-56.41
0.29
--
-1.00
2.31
Peer Median
12.68
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-48.65

Lower than Peers by 69.81

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
-48.65
-1,504.96
--
--
53.58
Peer Median
21.17
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-111.18

Lower than Peers by 137.42

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
-111.18
-1,377.12
-136.77
-5.54
33.29
Peer Median
26.24
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-36.42

Lower than Peers by 76.75

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
-36.42
-9.81
-1.13
--
--
Peer Median
40.34
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-1,133.81

Lower than Peers by 1,147.75

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
-1,133.81
--
--
--
--
Peer Median
13.94
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
--
-1.99
3.73
-0.24
--
Peer Median
0.18
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

-1.01

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
-1.01
-0.94
1.86
-0.12
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.14

Lower than Peers by 1.50

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
0.14
0.09
0.40
0.12
--
Peer Median
1.64
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.10

Lower than Peers by 1.53

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
0.10
0.04
0.15
0.12
--
Peer Median
1.64
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-13.87

Lower than Peers by 31.26

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
-13.87
-21.11
-7.25
--
-8.55
Peer Median
17.38
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

14.96

Higher than Peers by 4.05

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
14.96
4.87
20.66
--
--
Peer Median
10.91
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.12

Lower than Peers by 0.39

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
0.12
0.53
0.63
--
11.37
Peer Median
0.51
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
--
38.21
41.13
--
10.91
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
--
61.80
106.25
--
0.76
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
--
99.83
82.30
--
3.26
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
--
0.18
65.08
--
8.41
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
--
--
--
-1.68
--
Peer Median
21.76
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

1.81

Lower than Peers by 3.17

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
1.81
--
--
-1.68
--
Peer Median
4.98
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

--

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
--
--
--
-1.93
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

3

Lower than Peers by 4,697

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Trxade Group Inc (MEDS)
3
--
--
--
--
Peer Median
4,700
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...